Ameriprise Financial
AMP
$492.19
-0.93%
Ameriprise Financial is a diversified US financial services company whose core franchise is advice and wealth management, supported by a large asset management arm (Columbia Threadneedle) and a retirement and protection solutions business that sells insurance products to advisory clients. With roughly 10,600 affiliated and employee advisors and approximately $1.69 trillion in total assets under management and advisory across segments, Ameriprise is one of the larger US-based wealth managers and is best characterized as a scaled, fee-based advice platform with a vertically integrated product shelf rather than a pure asset manager. The current investor debate centers on the durability of organic advisor recruiting and client asset growth against a backdrop of market-sensitive fee revenue, margin expansion from operating leverage, and the capital-return story supported by consistent buybacks and dividends. Recent quarterly results showed revenue growth reaccelerating to double digits year over year, which has kept the narrative focused on whether wealth management flows and expense discipline can sustain earnings momentum as the stock trades at a discount to its own historical valuation band.…
AMP
Ameriprise Financial
$492.19
AMP 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ameriprise Financial's 12-month outlook, with a consensus price target around $554.64 and implied upside of +12.7% versus the current price.
Average Target
$554.64
0 analysts
Implied Upside
+12.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$445 - $638
Analyst target range
Coverage is solid with 11 analysts, and the consensus recommendation is Buy with a recommendation mean of 2.5, though the distribution is mixed — recent ratings include Buy/Outperform from Argus, RBC, and Jefferies alongside Neutral/Market Perform from Piper Sandler, KBW, and BMO, and an Underweight from Morgan Stanley. The average target price of $566.00 implies roughly 13.0% upside from the current $500.80, a moderately bullish signal that is tempered by the split between bulls and skeptics. Consensus EPS estimates of $67.83 (range $66.20 to $70.39) and revenue estimates of $24.05 billion (range $23.61 billion to $24.75 billion) underpin that target.
The full target range of $483.00 to $638.00 is wide — a 32% spread from low to high — signaling meaningful disagreement about the outlook. The high target of $638.00 implies roughly 27% upside and likely assumes multiple expansion toward historical norms, sustained double-digit revenue growth, and continued capital returns, while the low target of $483.00 sits below the current price and prices in margin compression, weaker flows, or a broader market de-rating. The pattern of ratings shows no recent upgrades — most actions are reiterations, with Morgan Stanley maintaining Underweight through July 2026 — suggesting conviction is stable rather than improving, and the wide spread combined with the mixed distribution means investors should treat the consensus target as a central tendency around a genuinely uncertain range rather than a high-conviction signal.
Drowning in data?
Find the real signal!
Bulls vs Bears: AMP Investment Factors
The bull case currently has stronger evidence: revenue is accelerating at 11.55% YoY, operating margin expanded 539bp sequentially to 30.44%, FCF of $8.064B comfortably funds $931M of quarterly capital return, and the stock trades at 9.71x forward earnings against a $566 average target. The bear case rests on price action and margin mix rather than deteriorating fundamentals — the -7.41% one-month move and 44.66% gross margin are real, but neither yet breaks the earnings trajectory. The single most important tension is whether the forward-PE discount is a value gap or a structural de-rating: if Q3 flows and margins confirm the Q2 operating leverage, the 9.71x multiple re-rates toward the 13x trailing level and the $566 target is achievable; if gross margin compression continues and flows weaken, the market's skepticism is validated and the $483 low target becomes the anchor.
Bullish
- Double-digit revenue reacceleration: Q2 2026 revenue of $5.013B grew 11.55% YoY from $4.494B, accelerating from Q1 2026's $4.886B and building on Q4 2025's $5.048B. The Advice & Wealth Management segment generated $3.319B of that total, confirming the fee-based advice engine is driving growth rather than a one-off insurance gain.
- Forward PE under 10x: At $500.80, AMP trades at 9.71x forward EPS versus 13.29x trailing, a 27% compression that implies the market expects meaningful earnings growth. Consensus EPS of $67.83 against a $500.80 price means the stock is priced for roughly a 10x multiple on next year's earnings — cheap in absolute terms for a business growing revenue 11.55%.
- Operating leverage expanding margins: Operating margin jumped to 30.44% in Q2 2026 from 25.05% in Q1, and net margin rose to 22.2% from 18.7%, even as gross margin compressed to 44.66% from 50.31%. The gap between gross and operating margin shows expense discipline is doing the heavy lifting on profitability.
- Heavy capital return, internally funded: Q2 2026 free cash flow of $2.849B on operating cash flow of $2.886B funded $779M of buybacks and $152M of dividends while cash still grew to $11.159B. TTM FCF of $8.064B against a $46.5B market cap implies a 5.6x PCF, and the 16.7% payout ratio leaves substantial room to keep shrinking the share count (91.8M from 100M diluted a year earlier).
Bearish
- Recent momentum sharply negative: AMP is down 7.41% over one month and 5.13% over three months, trailing SPY by 8.63 and 7.82 percentage points respectively. The September slide from $559 to $485 was a -21.1% drawdown from the August high of $572.56, and the stock now sits at just 55.9% of its 52-week range.
- Gross margin compression: Gross margin fell to 44.66% in Q2 2026 from 50.31% in Q1 and 50.07% in Q2 2025, a roughly 540bp YoY decline. If operating expense leverage stalls, this mix-driven compression flows directly into earnings and undermines the forward-PE discount thesis.
- Split analyst conviction: Despite a Buy consensus, the distribution is genuinely mixed: Argus, RBC and Jefferies are positive while Piper Sandler, KBW and BMO are Neutral and Morgan Stanley is Underweight. The $483-$638 target range is a 32% spread, and the low target sits below the current price — a sign of real disagreement, not a high-conviction setup.
- Valuation discount may be structural: The 13.29x trailing PE sits in the lower-middle of a band that ran from 9.46x (Q2 2026) to 20.44x (Q1 2025), and P/B has fallen from 10.10x in Q4 2024 to 7.10x. The market has consistently de-rated the insurance-linked earnings volatility and the diversified-financial structure, so the discount may not close on flows alone.
AMP Technical Analysis
AMP is in a broad, choppy uptrend that has lost its earlier momentum: the stock is up 7.07% over the past year but sits at $500.80, which is 55.9% of its 52-week range of $422.37 to $572.56, placing it in the middle of the band rather than at highs or lows. The path has been uneven — a strong run from roughly $456 in late April to a peak near $570 in mid-August gave way to a sharp September drawdown, with a maximum drawdown of -21.1% from that high. This mid-range positioning suggests neither a momentum breakout nor a distressed value setup, but rather a stock digesting a large prior advance.
Short-term momentum is clearly negative and diverging from the longer-term trend: the stock is down 7.41% over the past month and 5.13% over three months, even as it remains up 7.07% over twelve months and 9.78% over six months. That divergence — a positive 1-year return paired with a negative 1-month and 3-month return — points to mean reversion or a temporary pullback within a longer uptrend rather than a confirmed trend reversal, though the September slide from $559 to $485 was sharp enough to warrant caution. Relative strength confirms the underperformance: AMP trails SPY by 8.63 percentage points over one month and 7.82 points over three months, while its 6-month relative strength is a positive 2.30 points, showing the weakness is recent rather than chronic.
Key technical levels are the 52-week high of $572.56 as resistance and the 52-week low of $422.37 as major support, with the recent September low around $485 acting as an intermediate floor that has so far held. A breakout above $572.56 would signal a resumption of the primary uptrend and likely require a catalyst such as strong third-quarter flows or a favorable rate backdrop, while a breakdown below $485 would put the $422.37 low in play and confirm the September decline as more than a pullback. With a beta of 1.156, AMP is roughly 16% more volatile than the market, meaning position sizing should account for amplified moves relative to SPY, and the short ratio of 3.96 days indicates moderate short interest that could add fuel to either direction on a surprise.
Beta
1.16
1.16x market volatility
Max Drawdown
-21.1%
Largest decline past year
52-Week Range
$422-$573
Price range past year
Annual Return
+2.9%
Cumulative gain past year
| Period | AMP Return | S&P 500 |
|---|---|---|
| 1m | -2.1% | -1.0% |
| 3m | -6.9% | +2.9% |
| 6m | +6.0% | +6.5% |
| 1y | +2.9% | +13.1% |
| ytd | -0.3% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AMP Fundamental Analysis
Revenue is growing at a healthy clip: Q2 2026 revenue of $5.013 billion rose 11.55% year over year from $4.494 billion in Q2 2025, and the multi-quarter trend shows acceleration from Q1 2026's $4.886 billion and Q4 2025's $5.048 billion. The segment mix underscores the wealth management engine — Advice and Wealth Management generated $3.319 billion, versus $975 million from Retirement and Protection Solutions and $947 million from Asset Management — meaning the advice franchise is the dominant revenue driver and the key swing factor for growth. The trajectory implies the investment case rests on organic client asset growth and advisor productivity, with the double-digit top-line growth supporting the thesis that Ameriprise can compound earnings faster than a mature asset manager.
Profitability is robust and improving: Q2 2026 net income was $1.113 billion on a 22.2% net margin, up from $915 million and an 18.7% net margin in Q1 2026, while gross margin came in at 44.66% for the quarter versus 50.31% in Q1. The gross margin compression is offset by operating leverage — operating margin reached 30.44% in Q2 versus 25.05% in Q1 — and the company's 25.54% operating margin and 18.84% net margin are strong for the asset management industry, reflecting the fee-based, capital-light nature of the advice business. Trailing EPS of $12.12 in Q2 and $9.81 in Q1 show earnings power well above the $0.077 metric in the key-metrics snapshot, which appears to be a data artifact rather than a true earnings figure.
Balance sheet and cash flow metrics are solid for a financial: debt-to-equity is 0.895, the current ratio is an unusually high 25.84, and free cash flow TTM is $8.064 billion, with Q2 2026 free cash flow of $2.849 billion on operating cash flow of $2.886 billion. The company returned substantial capital in Q2 — $779 million in buybacks and $152 million in dividends — while still growing cash to $11.159 billion, demonstrating that growth is internally funded rather than dependent on external financing. ROE of 54.4% is exceptionally high, though it is flattered by the capital-light, high-equity-multiplier structure typical of wealth managers; the 1.28% dividend yield with a low 16.7% payout ratio leaves ample room for continued buybacks and dividend growth.
Quarterly Revenue
$5.0B
2026-06
Revenue YoY Growth
+11.6%
YoY Comparison
Gross Margin
44.7%
Latest Quarter
Free Cash Flow
$8.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AMP Overvalued?
Because net income is positive ($1.113 billion in Q2 2026), the PE ratio is the primary metric: AMP trades at a trailing PE of 13.29x and a forward PE of 9.71x, a 27% discount between trailing and forward multiples that implies the market expects meaningful earnings growth over the next twelve months. The forward multiple below 10x is low in absolute terms and suggests either a value opportunity or skepticism about the sustainability of current earnings, particularly given the stock's recent underperformance.
Against the asset management industry, AMP's 13.29x trailing PE and 2.46x PS ratio look inexpensive relative to the premium multiples typically awarded to scaled wealth platforms, and its 1.94x EV/Sales and 8.38x EV/EBITDA are moderate for a diversified financial with double-digit revenue growth. The PEG ratio of 1.39 is reasonable — not deep value, but not stretched — and the 7.10x price-to-book reflects the high-ROE, capital-light model rather than an asset-heavy balance sheet. The discount appears partly justified by the market's preference for purer asset managers and by the insurance-linked earnings volatility, but the gap versus peers with inferior growth leaves room for re-rating if flows hold up.
Historically, AMP's PE has ranged widely: it was 9.46x in Q2 2026, 11.53x in Q4 2025, 12.97x in Q3 2025, and as high as 20.44x in Q1 2025, while its price-to-book has fallen from 10.10x in Q4 2024 to 7.10x currently. The current 13.29x trailing PE sits in the lower-middle of that band and the 7.10x P/B is near the low end of its multi-year range, suggesting the market is pricing in cautious expectations rather than optimism — a setup that offers value if earnings growth materializes but risks further de-rating if growth slows.
PE
13.3x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 7x~17x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
8.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin mix and revenue concentration. Advice & Wealth Management produced $3.319B of Q2 2026's $5.013B revenue, so roughly two-thirds of the top line depends on a single segment whose fees are tied to client asset levels. Gross margin fell to 44.66% in Q2 from 50.31% in Q1 and 50.07% a year earlier, and while operating margin rose to 30.44%, that offset depends on continued expense discipline — if cost growth outpaces revenue, the 22.2% net margin compresses quickly. Debt-to-equity of 0.895 is moderate for a financial, but the insurance liabilities embedded in Retirement & Protection Solutions ($975M of Q2 revenue) add reserve and rate-sensitivity risk that a pure asset manager does not carry.
Market and competitive risks are dominated by valuation and beta. At 13.29x trailing and 9.71x forward earnings, AMP trades at a discount to premium wealth platforms, but the discount has persisted — P/B has fallen from 10.10x in Q4 2024 to 7.10x — suggesting the market structurally penalizes the diversified model and insurance-linked earnings volatility. A beta of 1.156 means a 10% market decline translates to roughly an 11.6% move, and because fee revenue is AUM-linked, market weakness hits revenue and multiple at the same time. Competition for advisor talent from independent broker-dealers and RIA aggregators threatens the 10,600-advisor recruiting engine, and the mixed analyst stance (Morgan Stanley Underweight, three Neutrals) shows conviction is not improving.
In a worst-case scenario, a market correction compresses AUM-linked fees, gross margin stays near 44.66%, advisor attrition accelerates, and the multiple de-rates toward the 9.46x trailing PE seen in Q2 2026. That combination would take the stock toward the $483 analyst low target, about -3.6% from $500.80, and a deeper break of the $485 September floor would put the 52-week low of $422.37 in play — roughly -15.7% from the current price. The historical max drawdown of -21.1% (from $572.56 to the September low) is the realistic stress-case magnitude, implying an investor could lose 15-21% in an adverse scenario before any recovery.

